• Novo Nordisk’s Sogroya moves closer towards EU approval pharmatimes
    February 02, 2021
    Novo Nordisk’s Sogroya (somapacitan) has received a positive opinion from the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use – moving closer towards approval in the EU.
PharmaSources Customer Service